Anaplastic Large Cell Lymphoma - 61 Studies Found Withdrawn : Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma : Lymphoma : 2007-08-06 : Biological: denileukin diftitox Drug: cycl Active, not recruiting : Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma : Lymphoma : 2007-02-20 : Drug: Alefacept Dose escalation theme. 0.075mg/kg by IV Weekly x 8 to 0.30mg/kg IV Weekly x 8 Completed : Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma : Lymphoma : 2005-10-12 : Biological: filgrastim 5mcg/kg Completed : MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma : Lymphoma : 2003-05-06 : Biological: iratumumab Completed : Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma : Lymphoma : 1999-11-01 : Biological: filgrastim Drug: carboplatin Completed : Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein : Neoplasms : 2002-11-08 : Drug: HeFi-1 Monoclonal Antibody Completed : Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma : Lymphoma Solid Tumor : 2007-05-03 : Drug: oxaliplatin 75-100 mg/m2 Completed : AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma : Lymphoma Prostate Cancer Sarcoma Biological: ganitumab Other: laboratory bi Recruiting : Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies : Lymphoid Malignancies Lymphoma Hodgkin Lymphoma : 2013-11-20 : Drug: Romidepsin Recruiting : Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies : Lymphoid Malignancies Multiple Myeloma Lymphoma : 2013-09-09 : Drug: Pralatrexate <<< Previous | Next >>>
